Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.94%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$22.65M
Gross Margin
63.95%
TTM Avg
66.50%
3Y Avg
67.57%
5Y Avg
61.13%
Market Cap
$21.37M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$21.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.64M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.72M
Gross Margin
-9.89%
TTM Avg
45.05%
3Y Avg
72.53%
5Y Avg
64.22%
Market Cap
$19.20M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $21.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.65M | 63.95% | 66.50% | 67.57% | 61.13% |
| Modular Medical, Inc. (MODD)vs › | $21.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quantum BioPharma Ltd. (QNTM)vs › | $21.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.64M | 0.00% | 0.00% | 0.00% | 0.00% |
| P3 Health Partners Inc. (PIII)vs › | $19.72M | -9.89% | 45.05% | 72.53% | 64.22% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | 91.37% | 69.42% | 78.99% | 53.34% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| NextCure, Inc. (NXTC)vs › | $19.14M | 0.00% | 0.00% | 0.00% | -18.00% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
